ARCHIVES

Investigation finds no evidence FDA’s Crawford had affair with subordinate.

This article is from The Cancer Letter archive.

Vol. 31 No. 23 | June 10, 2005

Download PDF Visit The Full Archive

Related Articles

CCI Gets Qualified Approval To Continue

January 18, 1980

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

Funding Opportunities: Department of Defense Ovarian Cancer Research

May 5, 2000

House Committee Adds $4.1 Billion To HHS Budget, Funds Not Expected To Help NIH.

May 12, 2006

Prevention Program Being Developed For Primary Providers

January 29, 1988

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013